| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |